Loading
SEC Form 13F · Q2 2026
Egerton Capital portfolio
John Armitage · Egerton Capital (UK) LLP · CIK 0001581811
Latest 13F for the quarter ended Jun 30, 2026, filed Jul 21, 2026, compared with the quarter ended Mar 31, 2026.
Reported 13F value$10.4B
Holdings23
Top 10 concentration76.0%
New positions5
Added to13
Reduced5
Closed6
What changed in Q2 2026
Estimated trade value from reported units and period-end values
New positions
Added to
Reduced
Closed
Holdings, Q2 2026
23 positions by reported value
| Holding | Portfolio weight | Reported value | Shares / units | Change vs prior quarter |
|---|---|---|---|---|
| VVISA INC · COM CL A | 14.13% | $1.5B | 4,264,651 | +3.7% |
| GOOGALPHABET INC · CAP STK CL C | 11.24% | $1.2B | 3,291,594 | -4.9% |
| APHAMPHENOL CORP · CL A | 8.29% | $858.1M | 4,866,688 | +69.5% |
| AMZNAMAZON COM INC · COM | 8.23% | $851.7M | 3,573,408 | +51.2% |
| MCOMOODYS CORP · COM | 7.46% | $771.9M | 1,704,229 |
Source: SEC Form 13F filings (latest filing on sec.gov). Information and analytics, not investment advice. Holdings are reported as of the quarter end, not live positions; reported 13F value covers securities listed on Form 13F and is not the fund's total assets under management.